MedPath

Does Benign Prostatic Obstruction Cause Hypertension?

Completed
Conditions
Prostatic Hyperplasia
Hypertension
Registration Number
NCT02347436
Lead Sponsor
St. Olavs Hospital
Brief Summary

The known correlation between benign prostatic hypertrophy (BPH) and hypertension could be explained by 3 theoretical pathway models. Whether hypertension causes BPH, BPH causes hypertension or the two are caused by a common factor is currently unknown.

In this study it will be investigated whether hypertension is due to the direct effects of infravesical obstruction to urinary outflow in patients with benign prostatic hyperplasia. The approach will be blood pressure measurement in patients who will have a resection of the prostate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • Listed for inguinal hernia repair or hydrocele repair or transurethral resection of the prostate
  • signed informed consent
Exclusion Criteria
  • Treatment with antihypertensive medication that has been started within 3 months of inclusion.
  • Treatment with antihypertensive medication that has been started after inclusion and before final blood pressure measurements have been obtained 6 months after operation.
  • Any reason that the investigator deems that the participant will not comply with follow-up.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change in blood pressure7,5 months

one measurement 6 weeks pre-surgery, and ambulatory measurement during 6 months post-surgery

Secondary Outcome Measures
NameTimeMethod
prostate symptom severity assessed by 'International prostate severity score' (questionnaire)7,5 months

assessed by 'International prostate severity score' (questionnaire)

Trial Locations

Locations (1)

St Olavs Hospital, Department of Urology

🇳🇴

Trondheim, Norway

St Olavs Hospital, Department of Urology
🇳🇴Trondheim, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.